Murat Kalayoglu insider trades
Open-market stock purchases and sales by Murat Kalayoglu, 10% Owner at Cartesian Therapeutics, Inc, from SEC Form 4 filings since Nov 13, 2023.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -100%.
Recent trades
Companies traded
- RNAC Cartesian Therapeutics, Inc: 1 buy, last Apr 2, 2026